Literature DB >> 557027

Molecular interactions between adriamycin and x-ray damage in mammalian tumor cells.

J E Byfield, Y C Lee, L Tu.   

Abstract

The effect of the anthracycline antibiotic, Adriamycin (Ad), on the sedimentation properties of pre-labelled mammalian DNA has been studied. Ad induces DNA degradation in vivo in both excision repair-competent (HeLa and Me-180) cells and in excision repair-deficient (REQ) cells. When X-irradiated cells are exposed to Ad during the period of repair of DNA single-strand breaks, small numbers of residual breaks persist following completion of repair. These are attributable to those induced by Ad alone. The effects of Ad and X-rays therefore appear to be similar and additive. No clear-cut evidence that Ad can inhibit the repair of X-ray-induced DNA single-strand breakage was found. Ad also induced the formation of DNA double-strand breaks and inhibits the repair of X-ray-induced base damage (repair replication). The induction of DNA strand breakage may be responsible for Ad cell toxicity and may contribute to its capacity to enhance primary X-irradiation damage when the two types of lesions co-exist.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557027     DOI: 10.1002/ijc.2910190208

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  Mutagenic effects of some anticancer antibiotics.

Authors:  B K Vig
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate.

Authors:  P A Volberding; M A Friedman; K J Resser; T L Phillips
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Response kinetics of host and experimental solid tumour after adriamycin.

Authors:  H A Hopkins; W B Looney; K Teja; A S Hobson; M S MacLeod
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

5.  Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.

Authors:  J E Byfield; J Murnane; J F Ward; P Calabro-Jones; M Lynch; F Kulhanian
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

6.  In vivo tumour-cell proliferation after adriamycin treatment.

Authors:  R Rowley; H A Hopkins; W B Looney
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.